Targeting the mitochondrial pyruvate carrier attenuates fibrosis in a mouse model of nonalcoholic steatohepatitis

MLA

ILKe Nalbantoglu, et al. “Targeting the Mitochondrial Pyruvate Carrier Attenuates Fibrosis in a Mouse Model of Nonalcoholic Steatohepatitis.” Hepatology, vol. 65, Mar. 2017, pp. 1543–56. EBSCOhost, https://doi.org/10.1002/hep.29025.

APA

ILKe Nalbantoglu, Hideji Fujiwara, Christopher L. Holley, Brian N. Finck, William G. McDonald, Elizabeth M. Brunt, Wesley T. Hodges, Kyle S. McCommis, Jean E. Schaffer, & Jerry R. Colca. (2017). Targeting the mitochondrial pyruvate carrier attenuates fibrosis in a mouse model of nonalcoholic steatohepatitis. Hepatology, 65, 1543–1556. https://doi.org/10.1002/hep.29025

Chicago

ILKe Nalbantoglu, Hideji Fujiwara, Christopher L. Holley, Brian N. Finck, William G. McDonald, Elizabeth M. Brunt, Wesley T. Hodges, Kyle S. McCommis, Jean E. Schaffer, and Jerry R. Colca. 2017. “Targeting the Mitochondrial Pyruvate Carrier Attenuates Fibrosis in a Mouse Model of Nonalcoholic Steatohepatitis.” Hepatology 65 (March): 1543–56. doi:10.1002/hep.29025.